Stay Updated
Press Releases
Taxpayers and U.S. Patients Pay Twice for Kite’s New CAR-T Drug
WASHINGTON, DC — The following statement was issued by David Mitchell, a cancer patient and the Founder of Patients For Affordable Drugs, regarding Kite’s decision tonight to price its CAR-T drug, Yescarta, at $373,000 per treatment. “Drug prices are out of control. As a cancer patient, I look forward to the potential of CAR-T drugs. […]
Press Releases
WASHINGTON, DC – In advance of today’s Senate HELP Committee hearing on drug prices, Patients For Affordable Drugs Executive Director, Ben Wakana issued the following statement: “Talk is cheap. Two of the worst abusers of America’s drug pricing system are witnesses at today’s hearing. We’ll inevitably hear a lot of blame shifting and dodging from […]
Press Releases
Patients For Affordable Drugs Launches National Campaign to Pass the CREATES Act
WASHINGTON, D.C. — Patients For Affordable Drugs announced a national campaign to help pass the CREATES Act, a bipartisan bill that would lower drug prices and save taxpayers billions. The legislation prevents brand drug manufacturers from gaming our system and blocking cheaper generic drugs from coming to market. The bill enjoys support from a bipartisan […]
Press Releases
Patients For Affordable Drugs Statement on Governor Brown Signing SB 17
LA PUENTE, CA — The following statement was issued by Victoria Stuessel, a Multiple Sclerosis patient, mother, and La Puente, CA resident seeking relief from skyrocketing drug prices. Victoria is a volunteer Patient Advocate in the Patients For Affordable Drugs community. “Patients like me can breathe a sigh of relief today. For years, I’ve struggled […]
Press Releases
WASHINGTON, DC—Patients For Affordable Drugs applauded a request led by U.S. Senator Maggie Hassan calling on Congress to investigate Allergan’s outrageous legal maneuver to transfer the patent of a blockbuster drug to the St. Regis Mohawk Tribe and maintain its monopoly. The anti-competitive and unprecedented legal dodge by the international drug corporation thwarts the will […]
Press Releases
Statement from Patients For Affordable Drugs on Novartis' Drug Price
WASHINGTON, DC — The following statement was issued by David Mitchell, Founder and President of Patients For Affordable Drugs, regarding Novartis’ decision to price its CAR-T drug, Kymriah, at $475,000 per treatment. “As a cancer patient, the potential of CAR-T is exciting and I applaud FDA’s approval. It means hope for hundreds of children and […]
Press Releases
Patients For Affordable Drugs Launches Campaign Demanding Fair Pricing of New Novartis Cancer Drug
WASHINGTON, DC – Patients for Affordable Drugs launched a national campaign today to demand pharmaceutical giant Novartis price its new cancer drug fairly and in accordance with the fact that American taxpayers invested over $200 million to help discover the drug. In a letter to the CEO of Novartis, Patients For Affordable Drugs requested a […]
Press Releases
Patients For Affordable Drugs Urges FDA to Stop Abuses by Drug Corporations
WASHINGTON, DC – Patients For Affordable Drugs President and founder David Mitchell will urge the Food and Drug Administration (FDA) to take action to boost generic competition and help fix out-of-control drug prices. At a public meeting today, Mitchell will share his story about how the out-of-pocket cost for Revlimid, a cancer drug he took […]